Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Comparison between the Fat Loss and Fat Gain Groups in the Results of the QuestionnairesFat loss (n = 17)Fat gain (n = 19)PSex0.542 Female: male6 (35.3%): 10 (58.8%)8 (42.1%): 11 (57.9%)Age (years)10.0 ± 2.410.3 ± 2.70.733Birthweight (kg)3.5 ± 0.53.2 ± 0.50.117Delivery type0.167 Vaginal: cesarean5 (29.4%): 12 (70.6%)11 (57.9%): 8 (42.1%)Duration of intervention (day)57.0 [55.0; 62.0]56.0 [51.0; 69.5]0.536Number of exercise counseling sessions0.165 One1 (5.9%)0 (0.0%) Two1 (5.9%)5 (26.3%) Three15 (88.2%)14 (73.7%)Number of nutritional counseling sessions0.382 One1 (5.9%)0 (0.0%) Two1 (5.9%)3 (15.8%) Three15 (88.2%)16 (84.2%)What did you feed your baby in the first year?0.747 Exclusive breastfeeding7 (41.2%)8 (42.1%) Exclusive formula feeding2 (11.8%)3 (15.8%) Mixed with predominant breastfeeding4 (23.5%)2 (10.5%) Mixed with predominant formula feeding4 (23.5%)6 (31.6%)How long do you study after school?0.540 Less than 1 h2 (11.8%)4 (21.1%) 1 to 2 h3 (17.6%)7 (36.8%) 2 to 3 h5 (29.4%)4 (21.1%) 3 to 4 h5 (29.4%)3 (15.8%) More than 4 h2 (11.8%)1 (5.3%)How long do you do perform regular exercise each day?0.767 None3 (18.8%)4 (21.1%) 30 min2 (12.5%)7 (36.8%) 30 min-1 h7 (43.8%)5 (26.3%) 1 to 2 h4 (25.0%)6 (31.6%) More than 2 h0 (0.0%)1 (5.3%)How long do you use electronic devices each day?0.504 Less than 2 h7 (41.2%)11 (57.9%) More than 2 h10 (58.8%)8 (42.1%)Is there an easily accessible place to exercise?1.000 Yes14 (82.4%)16 (84.2%) No3 (17.6%)3 (15.8%)How do you get to school?0.833 On foot12 (70.6%)15 (78.9%) By bus1 (5.9%)1 (5.3%) By private car4 (23.5%)3 (15.8%)Do you eat breakfast?0.308 Never6 (35.3%)2 (11.1%) 2 to 3 times a week0 (0.0%)1 (5.6%) 4 to 5 times a week2 (11.8%)3 (16.7%) Daily9 (52.9%)12 (66.7%)How long does it take to eat a meal?0.224 5 min0 (0.0%)3 (16.7%) 10 min6 (35.3%)5 (27.8%) 15 min8 (47.1%)4 (22.2%) 20 min2 (11.8%)5 (27.8%) More than 20 min1 (5.9%)1 (5.6%)How many times a week do you eat late-night snacks?0.990 Never8 (47.1%)10 (52.6%) 1 to 2 times a week7 (41.2%)7 (36.8%) 3 to 4 times a week1 (5.9%)1 (5.3%) Daily1 (5.9%)1 (5.3%)How many bottles of sugar-sweetened beverages do you drink a week?0.537 None2 (11.8%)0 (0.0%) 1 L bottle7 (41.2%)7 (46.7%) 2 L bottle6 (35.3%)5 (33.3%) 3 L bottle2 (11.8%)3 (20.0%)Data are expressed as counts (%)Comparison of the Results of Anthropometric Measurements and Blood Biochemical Profiles between the Pre: and Postintervention Stages in the Fat Loss and Fat Gain GroupsFat loss groupFat gain grouppre (n = 17)post (n = 17)pre (n = 19)post (n = 19)Anthropometric measurements Weight (kg)57.50 ± 16.9057.38 ± 16.7257.60 [49.40; 67.70]60.20 [50.00; 68.90]** Weight (z-score)2.38 ± 0.762.29 ± 0.77**2.16 [1.93; 2.50]2.20 [1.94; 2.64] Height (cm)145.76 ± 14.80146.78 ± 14.59**148.73 ± 14.62149.75 ± 14.59** Height (z-score)0.98 [0.17; 2.16]1.04 [0.18; 2.17]1.26 [0.75;1.46]1.15 [0.86; 1.48] BMI (kg/m2)26.41 ± 4.0426.01 ± 4.00**25.70 [23.75; 27.30]26.14 [23.94; 28.13]* BMI (z-score)2.54 [1.95; 2.76]2.36 [1.88; 2.65]**2.22 [1.96; 2.54]2.34 [2.02; 3.54] Systolic blood pressure (mmHg)119.71 ± 13.74118.18 ± 9.34121.05 ± 11.71119.26 ± 11.96 Diastolic blood pressure (mmHg)77.00 [70.00; 82.00]76.00 [69.00; 83.00]72.05 ± 10.3173.63 ± 10.72 Waist circumference (cm)88.90 [75.00; 93.20]84.50 [74.80; 93.90]**88.81 ± 13.2690.07 ± 13.64* Waist-to-height ratio0.58 [0.54; 0.61]0.56 [0.53; 0.60]**0. 59 [0.55; 0.62]0.59 [0.56; 0.62] Total body fat (%)38.30 [35.60; 43.0]37.2 [34.40; 39.70]**38.79 ± 5.1639.34 ± 5.06* Skeletal muscle mass (kg)17.70 [13.90; 21.80]18.20 [14.20; 26.90]**17.80 [15.70; 22.70]19.40 [16.00; 23.80] Total body fat (kg)22.80 ± 7.8921.99 ± 7.40**21.60 [18.80; 26.80]23.20 [19.20; 28.20]** Visceral Fat (cm2)112.10 [74.30; 144.20]105.10 [71.90; 136.80]**118.76 ± 49.54123.76 ± 49.10** Abdomen fat (%)0.85 ± 0.080.85 ± 0.080.86 ± 0.100.87 ± 0.09Blood biochemical profiles Glucose (mg/dL)98.00 [95.00; 103.00]99.00 [98.00; 103.00]104.00 [100.0; 106.0]99.00 [95.50; 107.00] AST (IU/L)24.00 [21.00; 29.00]24.00 [19.00; 26.00]24.000 [20.50; 30.50]24.00 [20.00; 28.50] ALT (IU/L)20.0 [17.00; 35.00]18.00 [16.00; 24.00]*25.00 [15.00; 46.50]26.00 [15.00; 42.50] Total cholesterol (mg/dL)177.00 ± 30.20176.18 ± 31.84169.58 ± 22.99173.84 ± 18.90 Triglyceride (mg/dL)90.00 [68.00; 117.00]91.00 [67.00; 108.00]77.00 [72.00; 115.00]86.00 [64.00; 137.50] HDL cholesterol (mg/dL)50.94 ± 11.1751.18 ± 10.6752.47 ± 10.1153.37 ± 10.87 LDL cholesterol (mg/dL)108.29 ± 24.00107.06 ± 27.04102.32 ± 22.18104.74 ± 19.33 hs-CRP (mg/L)1.40 [0.60; 2.60]1.40 [0.70; 1.90]1.20 [0.80; 1.60]1.60 [0.80; 2.00] Uric acid (mg/L)4.90 [4.40; 5.40]4.80 [4.50; 5.50]5.51 ± 0.935.79 ± 0.74 25-OH vitamin D (ng/mL)16.08 ± 5.8116.92 ± 6.4413.63 ± 4.3316.72 ± 5.92 Ferritin (ng/mL)64.50 [48.30; 83.70]68.70 [51.90; 96.20]54.90 [41.40; 139.60]59.80 [46.55; 111.75] Insulin (μU/mL)15.54 [10.75; 27.49]11.63 [8.17; 16.12]**19.29 [11.90; 39.21]13.93 [10.43; 22.91]** HbA1c (%)5.4 ± 0.35.4 ± 0.25.40 [5.35; 5.50]5.40 [5.30; 5.50] HOMA-IR1.33 [1.22; 1.42]2.67 [2.05; 3.84]**1.39 [1.33; 1.46]2.99 [2.60; 6.17]**Data are expressed as the means ± standard deviations or medians (interquartile ranges). *P < 0.05,**P < 0.01 paired t-test or Wilcoxon’s signed-rank test between the pre: vs postintervention stages in the fat loss and fat gain groups.

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Multiple reported designs.

Multiple reported designs

More than one design is explicitly reported; examine the supporting methods.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This longitudinal cohort study was an analysis of fecal samples collected from obese children before and after a 2-month weight reduction program.

Source: Methods.

We recruited 50 obese children aged 7 to 18 years old at Hallym University Kangnam Sacred Heart Hospital from August 2018 to August 2019.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Lifestyle modifications result in alterations in the gut microbiota in obese children

Multiple reported designs · BMC Microbiology · 2021

Original publication title

Lifestyle modifications result in alterations in the gut microbiota in obese children

Ky Young Cho

© The Author(s) 2021

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This study demonstrated that lifestyle modifications can impact the composition, richness, and predicted functional profiles of the gut microbiota in obese children after weight changes.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

The association between the gut microbiota and pediatric obesity was analyzed in a cross-sectional study. A prospective study of obese children was conducted to assess the gut microbial alterations after a weight change. We collected fecal samples from obese children before and after a 2-month weight reduction program that consisted of individual counseling for nutritional education and physical activity, and we performed 16S rRNA gene amplicon sequencing using an Illumina MiSeq platform.

Source: Background

Abstract: Results

Thirty-six participants, aged 7 to 18 years, were classified into the fat loss (n = 17) and the fat gain (n = 19) groups according to the change in total body fat (%) after the intervention. The baseline analysis of the gut microbiota in the preintervention stages showed dysbiotic features of both groups compared with those of normal-weight children. In the fat loss group, significantly decreased proportions of Bacteroidetes phylum, Bacteroidia class, Bacteroidales order, Bacteroidaceae family, and Bacteroides genus, along with increased proportions of Firmicutes phylum, Clostridia class, and Clostridiales order, were observed after intervention.

The microbial richness was significantly reduced, without a change in beta diversity in the fat loss group. The fat gain group showed significantly deceased proportions of Firmicutes phylum, Clostridia class, Clostridiales order, Lachnospiraceae family, and Eubacterium hallii group genus, without a change in diversity after the intervention. According to the functional metabolic analysis by the Phylogenetic Investigation of Communities by Reconstruction of Unobserved States 2, the “Nitrate Reduction VI” and “Aspartate Superpathway” pathways were predicted to increase significantly in the fat loss group.

The cooccurring networks of genera were constructed and showed the different microbes that drove the changes between the pre: and postintervention stages in the fat loss and fat gain groups.

Source: Results

Abstract: Conclusions

This study demonstrated that lifestyle modifications can impact the composition, richness, and predicted functional profiles of the gut microbiota in obese children after weight changes.

Source: Conclusions
Authors’ abstract

Background

The association between the gut microbiota and pediatric obesity was analyzed in a cross-sectional study. A prospective study of obese children was conducted to assess the gut microbial alterations after a weight change. We collected fecal samples from obese children before and after a 2-month weight reduction program that consisted of individual counseling for nutritional education and physical activity, and we performed 16S rRNA gene amplicon sequencing using an Illumina MiSeq platform.

Results

Thirty-six participants, aged 7 to 18 years, were classified into the fat loss (n = 17) and the fat gain (n = 19) groups according to the change in total body fat (%) after the intervention. The baseline analysis of the gut microbiota in the preintervention stages showed dysbiotic features of both groups compared with those of normal-weight children. In the fat loss group, significantly decreased proportions of Bacteroidetes phylum, Bacteroidia class, Bacteroidales order, Bacteroidaceae family, and Bacteroides genus, along with increased proportions of Firmicutes phylum, Clostridia class, and Clostridiales order, were observed after intervention.

The microbial richness was significantly reduced, without a change in beta diversity in the fat loss group. The fat gain group showed significantly deceased proportions of Firmicutes phylum, Clostridia class, Clostridiales order, Lachnospiraceae family, and Eubacterium hallii group genus, without a change in diversity after the intervention. According to the functional metabolic analysis by the Phylogenetic Investigation of Communities by Reconstruction of Unobserved States 2, the “Nitrate Reduction VI” and “Aspartate Superpathway” pathways were predicted to increase significantly in the fat loss group.

The cooccurring networks of genera were constructed and showed the different microbes that drove the changes between the pre: and postintervention stages in the fat loss and fat gain groups.

Conclusions

This study demonstrated that lifestyle modifications can impact the composition, richness, and predicted functional profiles of the gut microbiota in obese children after weight changes.

Trial registration

ClinicalTrials.govNCT03812497, registration date January 23, 2019, retrospectively registered.

Supplementary information

Supplementary information accompanies this paper at 10.1186/s12866-020-02002-3.

Publication and source details

Original title: Lifestyle modifications result in alterations in the gut microbiota in obese children

Ky Young Cho

BMC Microbiology · 2021

© The Author(s) 2021https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.http://dx.doi.org/10.13039/501100002701Ministry of EducationNRF-2018R1D1A1B07046799Cho Ky Young http://dx.doi.org/10.13039/501100002632Hallym UniversityHURF-2017-81Cho Ky Young

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T13:41:23.448912+00:00

DOI: 10.1186/s12866-020-02002-3 · PMC7789654